HomeCOPN • VIE
add
Cosmo Pharmaceuticals NV
Previous close
€49.60
Day range
€49.60 - €50.50
Year range
€48.80 - €81.50
Market cap
820.08M CHF
Avg Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 65.28M | 165.79% |
Operating expense | 23.21M | 23.28% |
Net income | 28.62M | 566.58% |
Net profit margin | 43.85 | 275.54% |
Earnings per share | — | — |
EBITDA | 33.11M | 1,488.93% |
Effective tax rate | 11.58% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 142.96M | 184.36% |
Total assets | 646.77M | 22.95% |
Total liabilities | 141.68M | 15.73% |
Total equity | 505.09M | — |
Shares outstanding | 16.02M | — |
Price to book | 1.59 | — |
Return on assets | 11.97% | — |
Return on capital | 15.26% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 28.62M | 566.58% |
Cash from operations | 31.61M | 775.09% |
Cash from investing | -19.69M | -136.31% |
Cash from financing | -17.43M | 81.08% |
Net change in cash | -5.13M | 85.01% |
Free cash flow | 25.42M | 1,938.72% |
About
Founded
1997
Website
Employees
322
